Skip to content
Open access

Elevated risk of first-time pulmonary hypertension among COVID-19 survivors: a 4.5-year longitudinal study

Aug 2026 · ERJ Open Research · Vol 12 · 0 citations · 44 references
Medicine

TL;DR

SARS-CoV-2 infection is independently associated with elevated long-term risk of new-onset PH, whereas only hospitalised COVID-19 status is associated with higher risk of downstream PH-related complications, which underscores the importance of ongoing PH surveillance in COVID-19 survivors.

Abstract

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could result in pulmonary vascular injury, systemic inflammation, and endothelial dysfunction, which could increase future risk of pulmonary hypertension (PH) and related complications. Methods We conducted a retrospective cohort study from the Montefiore Medical Center (Bronx, NY, USA) (1 March 2020 to 17 August 2024). Patients who had a COVID-19 PCR test were compared to those who did not have a positive COVID-19 PCR test on record. There were 15 721 hospitalised COVID-19 patients, 43 740 non-hospitalised COVID-19 patients, and 870 458 contemporary COVID-negative controls, and 634 892 historical (1 May 2016 to 31 December 2019) controls. The main analysis used propensity score matching for demographics, tobacco, substance use disorder, vaccination for SARS-CoV-2, and pre-existing comorbidities. New-onset PH and PH-related complications were assessed using Fine–Gray subdistribution hazard ratios (sHR). Sensitivity analyses included multivariable cause-specific Cox proportional hazard model, inverse probability weighting, and using matched historical cohort as controls. Long-term PH-related complications included heart failure, chronic kidney disease, and all-cause mortality compared to matched controls. Blood biomarkers during acute COVID-19 were analysed with respect to new-onset PH. Results Compared to propensity-matched COVID-negative controls, COVID-19 hospitalised patients were (sHR) 1.41 (95% CI 1.27–1.57) times more likely to experience new-onset PH, and COVID-19 non-hospitalised patients were 1.42 (95% CI 1.25–1.61) times more likely to do so. Sensitivity analyses corroborated our main findings. Among those with new-onset PH, only hospitalised COVID-19 survivors had higher risks of subsequent heart failure (sHR 1.61, 95% CI 1.11–2.35), chronic kidney disease (2.18, 1.50–3.16), and all-cause mortality (1.81, 1.47–2.24) compared to matched controls. Abnormal troponin (sHR 1.61, 95% CI 1.05–2.48), brain natriuretic peptide (1.59, 1.20–2.11) and creatinine (1.24, 1.01–1.51) during acute COVID-19 were associated with outcomes, but not D-dimer, ferritin and haematological markers. Conclusions SARS-CoV-2 infection is independently associated with elevated long-term risk of new-onset PH, whereas only hospitalised COVID-19 status is associated with higher risk of downstream PH-related complications. These findings underscore the importance of ongoing PH surveillance in COVID-19 survivors.

Read PDF

Similar papers

Open access Sep 2026

SARS-CoV-2 infection and two-year longitudinal clinical trajectory in pulmonary hypertension: a single-center retrospective exploratory cohort study

Introduction SARS-CoV-2 may promote endothelial injury, pulmonary vascular inflammation, and thrombosis, mechanisms relevant to pulmonary hypertension (PH), but longitudinal post-COVID-19 trajectories in established PH remain poorly defined. Methods We retrospectively analysed 40 PH patients in the prospectively establ...

A. Al-Qahtani, F. Alzubi, D. Obeid et al. · 0 citations
Open access Sep 2026

COVID-19 and subsequent risk of coded diabetic retinopathy in patients with type 2 diabetes: a multicenter propensity score-matched cohort study

Among adults with T2DM, COVID-19 was associated with an increased risk of EHR-recorded incident DR, including coded vision-threatening subtypes (proliferative DR and diabetic macular edema), during follow-up, and COVID-19 was associated with increased risks of glycemic events.

K.-C. Hung, Ting-Sian Yu, Su-Juan Wu et al. · 0 citations
Open access Oct 2026

Trends and Outcomes of COVID-19 Hospitalizations Among Patients with Hypertension: Insights from United States National Inpatient Sample, 2020–2022

Overall, hypertension was associated with increased inpatient morbidity and a complicated hospital course among hospitalizations with COVID-19, despite lower adjusted odds of in-hospital mortality.

A. Arumairaj, D. Dhanani, Anuradha Shunmugam Veluswamy et al. · 2 citations
Open access Aug 2026

Cardiovascular, Renal, and Pulmonary Risks of Long COVID: A Retrospective Cohort Study Stratified by Age and Sex.

BACKGROUND A substantial proportion of patients with acute COVID-19 develop postacute sequelae of SARS-CoV-2 infection (Long COVID). The risk of adverse cardiovascular and related outcomes in Long COVID remains elusive. We hypothesized that individuals with Long COVID are at elevated risk for adverse cardiovascular, re...

Akash Pradeep, Izola Ramalho, Martha L. Carvour et al. · 0 citations
Aug 2026

New Cardiovascular Diagnoses, Symptoms and Functional Status Following SARS-CoV-2 Infection in a National Cohort of 1,734 Patients in Italy.

It is suggested that new cardiovascular diagnoses following COVID-19 significantly affect subsequent wellbeing and preventing their occurrence may reduce not only acute and post-acute cardiovascular morbidity, but also the persistence, breadth, and burden of post-COVID-19 symptoms, and may avert a significant decline i...

M. Floridia, G. Parati, D. Soranna et al. · 0 citations
Open access Oct 2026

Long-COVID Associated With Incident Hypertension: A Population-Based Cohort Study.

BACKGROUND Long COVID has been linked to persistent autonomic and vascular abnormalities, but its impact on hypertension among non-hospitalized COVID-19 convalescents remains unclear. Given the link between blood pressure and cardiovascular morbidity, understanding how long COVID modifies the risk of incident hypertens...

P. Lindberg, Samuel Wiqvist, Seika Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.